Rotations 2.0
A weekly discussion of medicine and science trends between people far too old to be trying something this new.
Rotations 2.0
Rotations 2.0 Episode 72 Rosacea
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Episode 72 Rosacea
Shoot me any comments or questions @Rotation2ptoh on X
Intro Music: KI Instrumental (Rock Celtic) by Lyrium-2025
Outro Music: Heartwide by Alex Grohl
Courtesy of Pixabay under Creative Commons non-commercial use.
Produced by: Todd Fredricks DO MSS
Edited by: Todd Fredricks DO MSS
Answers for Episode 71 Squamous Cell Carcinoma
Question 1
A 68‑year‑old patient presents to a family medicine clinic with a scaly, tender, hyperkeratotic plaque on the helix of the ear that has enlarged over 2 months. Shave biopsy confirms cutaneous squamous cell carcinoma (cSCC). The pathology report additionally notes tumor cells tracking along a nerve. The patient is otherwise healthy. Which is the most appropriate next step in management?
C. Arrange urgent dermatology (and/or head & neck) referral for high‑risk cSCC management planning
Question 2
A researcher examines the tumor microenvironment of cSCC and finds abundant regulatory T cells (Tregs)associated with high extracellular adenosine, which suppresses local anti‑tumor immunity. The researcher asks how these Tregs generate adenosine in the extracellular space. Which mechanism best explains the increased extracellular adenosine production?
C. Tregs express ectoenzymes CD39 and CD73 that metabolize extracellular ATP → adenosine
Question 3
A 79‑year‑old patient has locally advanced cSCC that is not amenable to curative surgery or radiation therapy. The oncology consultant recommends first‑line systemic therapy with a PD‑1 immune checkpoint inhibitor per evidence summarized in the review. Which regimen matches a PD‑1–targeted treatment dosing schedule described in the article?
B. Cemiplimab 350 mg IV every 3 weeks
Rosa, Ilenia, Lorenzo Pio Padula, Francesco Semeraro, Carlotta Marrangone, Antonio Inserra, Luisa De Risio, and Marta Boffa, et al. “Endocannabinoids, Depression, and Treatment Resistance: Perspectives on Effective Therapeutic Interventions.” Psychiatry Research 352 (2025): 116697.
Rotations 2.0 is copyrighted. But you can use any content from the podcast for non-commercial purposes under Creative Commons….BUT, BUT, BUT, you must cite Rotations 2.0 and Todd Fredricks DO MSS as the source of the material AND AND AND you cannot alter or edit the content in any manner without expressed permission of Todd Fredricks DO MSS.
Rotations 2.0 is made possible by the generous understanding and accommodation of my beloved institution, Ohio University. The comments and ideas expressed on Rotations 2.0 are that of the content creators alone and may not reflect official policy or the opinion of the Ohio University, the State of Ohio, or the US Government or any other state, person or governmental agency.
Listeners interested in specifics from the paper authors should contact them directly through their respective institutions.
Any therapeutic ideas discussed should not be taken as any kind of medical advice or recommendations by the content creators and the content creators are not offering medical advice but discussing topics from an academic perspective. Listeners seeking advice about any medical care or decision-making should consult their own physician or medical provider and the content creators of Rotations 2.0 assume no liability for any listener's care or decision-making stemming from the topics discussed on Rotations 2.0.